Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 170.06
-2.44 (-1.41%)
Jan 22, 2026, 3:47 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 198.16 million as of January 22, 2026. Its market cap has decreased by -5.30% in one year.
Market Cap
198.16M
Enterprise Value
205.77M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
170.06
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 198.16M, an increase of 270.65%. That is a compound annual growth rate of 13.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 198.16M | -3.79% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Biomedica | 1.07B |
| PureTech Health | 314.67M |
| Avacta Group | 229.72M |
| Scancell Holdings | 134.91M |
| Bioventix | 94.05M |
| 4basebio | 91.32M |
| SkinBioTherapeutics | 48.52M |
| Hemogenyx Pharmaceuticals | 41.56M |